JavaScript scheint in Ihrem Browser deaktiviert zu sein. Sie müssen JavaScript in Ihrem Browser aktivieren, um alle Funktionen in diesem Shop nutzen zu können.
Glioblastoma (Multiform)
Undifferentiated glioblastoma Species: Homo sapiens Tissue: CNS Properties: Adherent Cytogenic data: 5n+/-, Near-pentaploid 115+/- (104-126) Patient: Female, 67 yrs of age Medium: AddexBio-formulated RPMI-1640 Medium(C0004-01) + 10% FBS Subculture: 1:5 to 1:10 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37 C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, X CSF1PO: 10, 13 D13S317: 10, 10 D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
Homo sapiens Tissue: CNS Properties: Adherent Cytogenic data: 5n+/-, Near-pentaploid 115+/- (104-126) Patient: Female, 67 yrs of age Medium: AddexBio-formulated RPMI-1640 Medium(C0004-01) + 10% FBS Subculture: 1:5 to 1:10 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37 C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, X CSF1PO: 10, 13 D13S317: 10, 10 D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
CNS Properties: Adherent Cytogenic data: 5n+/-, Near-pentaploid 115+/- (104-126) Patient: Female, 67 yrs of age Medium: AddexBio-formulated RPMI-1640 Medium(C0004-01) + 10% FBS Subculture: 1:5 to 1:10 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37 C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, X CSF1PO: 10, 13 D13S317: 10, 10 D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
Adherent Cytogenic data: 5n+/-, Near-pentaploid 115+/- (104-126) Patient: Female, 67 yrs of age Medium: AddexBio-formulated RPMI-1640 Medium(C0004-01) + 10% FBS Subculture: 1:5 to 1:10 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37 C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, X CSF1PO: 10, 13 D13S317: 10, 10 D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
5n+/-, Near-pentaploid 115+/- (104-126) Patient: Female, 67 yrs of age Medium: AddexBio-formulated RPMI-1640 Medium(C0004-01) + 10% FBS Subculture: 1:5 to 1:10 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37 C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, X CSF1PO: 10, 13 D13S317: 10, 10 D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
Female, 67 yrs of age Medium: AddexBio-formulated RPMI-1640 Medium(C0004-01) + 10% FBS Subculture: 1:5 to 1:10 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37 C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, X CSF1PO: 10, 13 D13S317: 10, 10 D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
AddexBio-formulated RPMI-1640 Medium(C0004-01) + 10% FBS Subculture: 1:5 to 1:10 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37 C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, X CSF1PO: 10, 13 D13S317: 10, 10 D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
1:5 to 1:10 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37 C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, X CSF1PO: 10, 13 D13S317: 10, 10 D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, X CSF1PO: 10, 13 D13S317: 10, 10 D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, X CSF1PO: 10, 13 D13S317: 10, 10 D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, X CSF1PO: 10, 13 D13S317: 10, 10 D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, X CSF1PO: 10, 13 D13S317: 10, 10 D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, X CSF1PO: 10, 13 D13S317: 10, 10 D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, X CSF1PO: 10, 13 D13S317: 10, 10 D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, X CSF1PO: 10, 13 D13S317: 10, 10 D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, X CSF1PO: 10, 13 D13S317: 10, 10 D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
Amelogenin: X, X CSF1PO: 10, 13 D13S317: 10, 10 D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
CSF1PO: 10, 13 D13S317: 10, 10 D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
D13S317: 10, 10 D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
D16S539: 12, 13 D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
D5S818: 11, 12 D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
D7S820: 9, 13 THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
THO1: 9.3, 10 TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
TPOX: 8, 11 vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
vWA: 16, 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
If use of this culture results in a scientific publication, it should be cited in the publication as: SF-295 (AddexBio C0005005) Mutations in SF-295 Cells
Mutations in SF-295 Cells
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.
Arbeitsanleitung (Data Sheet) anfordern
Produkt-Datenblatt anfordern
Sicherheitsdatenblatt anfordern
Vergleichen
Auf den Wunschzettel
Angebot anfordern
Lieferzeit anfragen
Technische Frage stellen
Bulk-Anfrage stellen
sales@hoelzel.de
« Zurück
Pünktliche Lieferung zu Ihrem Wunschtermin und bei jeder 5. Bestellung 15% sparen.
Passwort vergessen?
Noch nicht registriert? Konto hier erstellen!